Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Neurological Disorder Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Neurological Disorder Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Neurological Disorder Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bayer AG.
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd
F Hoffmann-La Roche Ltd
AstraZeneca
Merck & Co
Novartis AG.
GlaxoSmithKline plc
By Type:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
By End-User:
Hospital
Clinic
Home
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurological Disorder Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Neurological Disorder Drugs Market Size and Growth Rate of Antipsychotic from 2014 to 2026
1.3.2 Japan Neurological Disorder Drugs Market Size and Growth Rate of Hypnotic & Sedative from 2014 to 2026
1.3.3 Japan Neurological Disorder Drugs Market Size and Growth Rate of Analgesics from 2014 to 2026
1.3.4 Japan Neurological Disorder Drugs Market Size and Growth Rate of Anticoagulants from 2014 to 2026
1.3.5 Japan Neurological Disorder Drugs Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Neurological Disorder Drugs Market Size and Growth Rate of Hospital from 2014 to 2026
1.4.2 Japan Neurological Disorder Drugs Market Size and Growth Rate of Clinic from 2014 to 2026
1.4.3 Japan Neurological Disorder Drugs Market Size and Growth Rate of Home from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Neurological Disorder Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Neurological Disorder Drugs by Major Types
3.4.1 Market Size and Growth Rate of Antipsychotic
3.4.2 Market Size and Growth Rate of Hypnotic & Sedative
3.4.3 Market Size and Growth Rate of Analgesics
3.4.4 Market Size and Growth Rate of Anticoagulants
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Neurological Disorder Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Neurological Disorder Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Neurological Disorder Drugs in Hospital
4.4.2 Market Size and Growth Rate of Neurological Disorder Drugs in Clinic
4.4.3 Market Size and Growth Rate of Neurological Disorder Drugs in Home
5 Market Analysis by Regions
-
5.1 Japan Neurological Disorder Drugs Production Analysis by Regions
-
5.2 Japan Neurological Disorder Drugs Consumption Analysis by Regions
6 Hokkaido Neurological Disorder Drugs Landscape Analysis
-
6.1 Hokkaido Neurological Disorder Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Neurological Disorder Drugs Landscape Analysis by Major End-Users
7 Tohoku Neurological Disorder Drugs Landscape Analysis
-
7.1 Tohoku Neurological Disorder Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Neurological Disorder Drugs Landscape Analysis by Major End-Users
8 Kanto Neurological Disorder Drugs Landscape Analysis
-
8.1 Kanto Neurological Disorder Drugs Landscape Analysis by Major Types
-
8.2 Kanto Neurological Disorder Drugs Landscape Analysis by Major End-Users
9 Chubu Neurological Disorder Drugs Landscape Analysis
-
9.1 Chubu Neurological Disorder Drugs Landscape Analysis by Major Types
-
9.2 Chubu Neurological Disorder Drugs Landscape Analysis by Major End-Users
10 Kinki Neurological Disorder Drugs Landscape Analysis
-
10.1 Kinki Neurological Disorder Drugs Landscape Analysis by Major Types
-
10.2 Kinki Neurological Disorder Drugs Landscape Analysis by Major End-Users
11 Chugoku Neurological Disorder Drugs Landscape Analysis
-
11.1 Chugoku Neurological Disorder Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Neurological Disorder Drugs Landscape Analysis by Major End-Users
12 Shikoku Neurological Disorder Drugs Landscape Analysis
-
12.1 Shikoku Neurological Disorder Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Neurological Disorder Drugs Landscape Analysis by Major End-Users
13 Kyushu Neurological Disorder Drugs Landscape Analysis
-
13.1 Kyushu Neurological Disorder Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Neurological Disorder Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Bayer AG.
14.1.1 Bayer AG. Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 F. Hoffmann-La Roche Ltd.
14.2.1 F. Hoffmann-La Roche Ltd. Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Teva Pharmaceutical Industries Ltd
14.3.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 F Hoffmann-La Roche Ltd
14.4.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 AstraZeneca
14.5.1 AstraZeneca Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Merck & Co
14.6.1 Merck & Co Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Novartis AG.
14.7.1 Novartis AG. Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 GlaxoSmithKline plc
14.8.1 GlaxoSmithKline plc Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
The List of Tables and Figures (Totals 151 Figures and 150 Tables)
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Antipsychotic from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Hypnotic & Sedative from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Analgesics from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Anticoagulants from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Hospital from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Clinic from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Home from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Neurological Disorder Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Neurological Disorder Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Neurological Disorder Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Neurological Disorder Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Antipsychotic
Figure Market Size and Growth Rate of Hypnotic & Sedative
Figure Market Size and Growth Rate of Analgesics
Figure Market Size and Growth Rate of Anticoagulants
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Neurological Disorder Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Neurological Disorder Drugs by Different End-Users from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Hospital from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Clinic from 2014 to 2026
Figure Japan Neurological Disorder Drugs Market Size and Growth Rate of Home from 2014 to 2026
-
Table Japan Neurological Disorder Drugs Production by Regions
-
Table Japan Neurological Disorder Drugs Production Share by Regions
-
Figure Japan Neurological Disorder Drugs Production Share by Regions in 2014
-
Figure Japan Neurological Disorder Drugs Production Share by Regions in 2018
-
Figure Japan Neurological Disorder Drugs Production Share by Regions in 2026
-
Table Japan Neurological Disorder Drugs Consumption by Regions
-
Table Japan Neurological Disorder Drugs Consumption Share by Regions
-
Figure Japan Neurological Disorder Drugs Consumption Share by Regions in 2014
-
Figure Japan Neurological Disorder Drugs Consumption Share by Regions in 2018
-
Figure Japan Neurological Disorder Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Hokkaido Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Neurological Disorder Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Tohoku Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Tohoku Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Tohoku Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Neurological Disorder Drugs Consumption Share by End-Users in 2026
-
Table Kanto Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Kanto Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Kanto Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Kanto Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Neurological Disorder Drugs Consumption Share by End-Users in 2026
-
Table Chubu Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Chubu Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Chubu Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Chubu Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Neurological Disorder Drugs Consumption Share by End-Users in 2026
-
Table Kinki Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Kinki Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Kinki Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Kinki Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Neurological Disorder Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Chugoku Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Chugoku Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Chugoku Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Neurological Disorder Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Shikoku Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Shikoku Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Shikoku Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Neurological Disorder Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Neurological Disorder Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Neurological Disorder Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Neurological Disorder Drugs Consumption Share by Types in 2014
-
Figure Kyushu Neurological Disorder Drugs Consumption Share by Types in 2018
-
Figure Kyushu Neurological Disorder Drugs Consumption Share by Types in 2026
-
Table Kyushu Neurological Disorder Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Neurological Disorder Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Neurological Disorder Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Neurological Disorder Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Neurological Disorder Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Bayer AG.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG.
Figure Sales and Growth Rate Analysis of Bayer AG.
Figure Revenue and Market Share Analysis of Bayer AG.
Table Product and Service Introduction of Bayer AG.
Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd.
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd.
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd.
Table Product and Service Introduction of F. Hoffmann-La Roche Ltd.
Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd
Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd
Table Product and Service Introduction of F Hoffmann-La Roche Ltd
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of Merck & Co
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co
Figure Sales and Growth Rate Analysis of Merck & Co
Figure Revenue and Market Share Analysis of Merck & Co
Table Product and Service Introduction of Merck & Co
Table Company Profile and Development Status of Novartis AG.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG.
Figure Sales and Growth Rate Analysis of Novartis AG.
Figure Revenue and Market Share Analysis of Novartis AG.
Table Product and Service Introduction of Novartis AG.
Table Company Profile and Development Status of GlaxoSmithKline plc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
Table Product and Service Introduction of GlaxoSmithKline plc
-
